FindTrial
Sign In

A study of cause-specific prevalence and mortality in patients with fatty liver from national data.

To study the cause-specific prevalence and mortality of patients with different types of fatty liver using national data from South Korea, the United States, and the United Kingdom.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009554
Enrollment
500000
Registered
2024-06-21
Start date
2024-05-03
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. participated in the National Health and Nutrition Examination Survey (1998-2022) and is included in the data provided by the National Health and Nutrition Examination Survey. - Wants to use public data provided as open data on the official websites of the US, Taiwan, and Korea's National Institutes of Health. 2. wishes to use public data available as open data on the official website of the UK biobank.

Exclusion criteria

Exclusion criteria: Subjects with insufficient test results to calculate liver fibrosis levels

Design outcomes

Primary

MeasureTime frame
Prevalence of cross-border fatty liver—

Secondary

MeasureTime frame
Degree of liver fibrosis in patients with fatty liver, overall mortality by country—

Countries

Korea, Republic of

Contacts

Public ContactDae Won Jun

Hanyang University

gongori1004@gmail.com+82-2-2290-8334

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026